Company / Profit Margin
Traws Pharma, Inc. Profit Margin History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-73682.7%
FY2024
5-year range
-73682.7% / -985.0%
FY2020-FY2024
Trend
-778.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -778% YoY in FY2024, a notable deviation from the 9-year average annual change of -268%.
Based on SEC 10-K filings.
-73682.7% in FY2024 with a 5-year CAGR of -72007.4%.
Declined from -7151.8% to -73682.7% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -62792.3pp
- 5-Year Change
- -72007.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, profit margin decreased 778.1% year-over-year.
- Peak profit margin was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -73682.7% | -778.1% |
| FY2023 | -8391.1% | -17.3% |
| FY2022 | -7151.8% | +34.3% |
| FY2021 | -10890.5% | -1005.6% |
| FY2020 | -985.0% | +41.2% |
| FY2019 | -1675.3% | +45.3% |
| FY2018 | -3061.3% | -763.2% |
| FY2017 | -354.6% | -69.4% |
| FY2016 | -209.3% | +97.4% |
| FY2015 | -7960.3% | -12191.9% |
As of FY2024 · SEC 10-K Annual Filings · Last checked Jun 28, 2026